Jul 15, 2007 Issue
Home Monitoring of Glucose and Blood Pressure [Article]

Home monitoring of blood glucose and blood pressure levels can provide patients and physicians with valuable information in the management of diabetes mellitus and hypertension. Home monitoring allows patients to play an active role in their care and may improve treatment adherence and clinical outc...

Jun 15, 2007 Issue
Therapies for Diabetes: Pramlintide and Exenatide [Article]

The American Diabetes Association currently recommends an A1C goal of less than 7 percent. However, many patients are unable to achieve this goal by using oral drug combinations or diet and exercise, leaving insulin as the only treatment option. In most cases, insulin is initiated later in therapy b...

May 15, 2007 Issue
Insulin Inhalation Powder (Exubera) for Diabetes Mellitus [STEPS]

Inhaled insulin provides an alternative route of administration for rapid-acting insulin but offers no other benefit over available insulin therapy. It may reduce, but not eliminate, the need for self-injection in patients with type 1 diabetes. In patients with type 2 diabetes, the risk of hypoglyce...

Feb 1, 2007 Issue
The Role of Exercise in Patients with Type 2 Diabetes [Cochrane for Clinicians]

Regular exercise reduces A1C levels, adiposity, and triglyceride levels. However, no research has definitively proved a benefit of exercise on patient-oriented outcomes such as diabetes-related morbidity and mortality.

Jan 15, 2007 Issue
CDC Releases Data on Visual Impairment in Patients with Diabetes [Practice Guidelines]

The Centers for Disease Control and Prevention (CDC) has released data on visual impairment in patients with diabetes. Patients with diabetes are more likely to be visually impaired than those who do not have the disease.

Dec 15, 2006 Issue
Pregabalin (Lyrica) for the Management of Pain Associated with Diabetic Neuropathy [STEPS]

Pregabalin is safe and effective for the management of neuropathic pain associated with diabetic peripheral neuropathy. Drawbacks include the cost and the lack of studies demonstrating equivalence or superiority to other treatments. However, pregabalin’s ease of dosing titration, minimal drug intera...

Sep 15, 2006 Issue
Tight Control of Type 1 Diabetes: Recommendations for Patients [Article]

Tight control of blood glucose levels and risk factors for cardiovascular disease (e.g., hypertension, hypercholesterolemia) can substantially reduce the incidence of microvascular and macrovascular complications from type 1 diabetes. Physicians play an important role in helping patients make essent...

Sep 1, 2006 Issue
ADA Releases Standards of Medical Care for Patients with Diabetes [Practice Guidelines]

The American Diabetes Association (ADA) has published a position statement containing evidence-based recommendations for diabetes care, treatment goals, and tools to evaluate the quality of care.

Aug 15, 2006 Issue
CDC Reports on End-stage Renal Disease in Patients with Diabetes [Practice Guidelines]

The Centers for Disease Control and Prevention (CDC) has released a report detailing the incidence of end-stage renal disease (ESRD) in patients with diabetes. Diabetes mellitus is the leading cause of ESRD in the United States, accounting for 44 percent of new cases in 2002.

Jul 15, 2006 Issue
Insulin Detemir (Levmir) for Diabetes Mellitus [STEPS]

Insulin detemir is suitable as basal insulin in a basal-bolus regimen. In limited research, it has been shown to cause slightly fewer episodes of minor hypoglycemia and no weight gain in patients with type 1 and 2 diabetes, which is a benefit that must be balanced against its higher price. Insulin d...

Pages: Previous 1 ... 7 8 9 10 11 12 13 14 15 16 17 Next

Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now